Compare Analog Devices, Inc. (ADI) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Analog Devices, Inc. vs 10X Genomics Inc — how do they compare? Analog Devices, Inc. trades at $389.54 (market cap $187.67B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: Analog Devices, Inc. is far larger — about 24.7× 10X Genomics Inc's market cap, and Analog Devices, Inc. pays a 1.14% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ADI | TXG | |
|---|---|---|
Market Cap | $187.67B | $7.61B |
Sector | Technology | Health |
52-Week High | $445.48 | $58.57 |
52-Week Low | $225.20 | $11.34 |
Enterprise Value | $192.92B | $7.14B |
Dividend Yield | 1.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Analog Devices, Inc.
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
